This Nasdaq Composite (COMP) In the middle of the afternoon was a strong performance with a strength of 2.4%.
This Dr. (INDU) Was 1.1%, or 300 points and above S&P 500 (SPX) 2% ch .i.
All three came close to the benchmark record area. The Nasdaq and the S&P 500 have been on the verge of beating their closing levels since early September, the last record of the Down was in pre-epidemic times.
Shares of Apple (AAPL) Both were among the top performers in the index. The tech giant is set to announce its new iPhone on Tuesday after weeks of delays related to the epidemic. Apple Pal shares traded up about 7%.
Meanwhile, shares of the Nasdaq-listed software company Twilio (TWLO) The rally was about%% after the company announced its intention to buy the data start-up segment for ૨ 3 billion.
Software stocks seem to dominate tech stocks in September, said Paul Hickey of Bespoke and Monday’s rally is proof of that.
Otherwise, Monday is Columbus Day holiday which is a quieter day in terms of economic news, but the third quarter revenue season is around the corner. The season begins with the big banks of America Citigroup (C) And JPMorgan (JPM) Began reporting on Tuesday.
Analysts at Goldam Sachs (G.S.) Think earnings will paint an uneven picture of corporate America, as some businesses have recovered from a devastating second quarter while others are still struggling.
In addition to earnings, the election is also fast approaching, with only three weeks left.
Analysts said in a note to consumers that “investors are focusing on the impact of the ‘Blue Wave’ election as the probability of a Democratic sweep has increased from 47% to 0% a month ago.
Investors will also have to keep an eye on headlines from Washington and Washington, where the Trump administration counter-offered stimulus to Democrats last week. Stocks will likely bounce back on the stimulus deal, but so far, after months of negotiations, all we got was volatility.
There are a lot of moving parts, but the most important factor for stocks is still the virus and the potential vaccine route, Goldman analysts said.
.
Related
